United Kingdom· GB-APID-5379311000001101
Emtriva 200mg capsules
A emtricitabine product containing emtricitabine, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Emtricitabine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AF09 (emtricitabine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Emtricitabine · ATC J05AF09
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of emtricitabine costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Emtricitabine · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$8.60
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Emtricitabine
- Manufacturer
- Gilead Sciences Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AF09
- ATC class
- Emtricitabine
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin05391507145604
- gtin5391507147448
- gtin05391507145840
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
32 interactions on record for emtricitabine.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Emtricitabine · interactions on record
32 records
- 4 severe
- 23 moderate
- 1 minor
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Emtricitabine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesemtricitabineCipla USA Inc.
- FinlandEmtrivaOrifarm Oy
- CzechiaEMTRIVAGilead Sciences Ireland UC, Carrigtohill
- FranceEMTRIVA 200 mg, géluleGILEAD SCIENCES IRELAND UC (IRLANDE)
- BelgiumEmtriva 200 mgGilead Sciences Ireland UC
- IcelandEmtrivaGilead Sciences Ireland UC*
- NetherlandsEmtriva 200 mg, harde capsulesGilead Sciences Ireland UC
- NorwayEmtrivaGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys
- Iceland · Emtriva
- Liechtenstein · Emtriva
- Norway · Emtriva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/466145dc-3d9e-43fc-ad35-48953b6acd2a GET /v1/drugs/466145dc-3d9e-43fc-ad35-48953b6acd2a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "5379311000001101",
"desc": "Emtriva 200mg capsules (Gilead Sciences Ltd)",
"form": "Oral capsule",
"vpid": "41762811000001109",
"source": "dmd",
"vtm_id": "775755005",
"strength": "200 mg",
"substance": "Emtricitabine",
"ingredient": "Emtricitabine",
"supplier_code": "2572301000001107"
}See everything about emtricitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.